Excellent Diagnostic And Research Agency Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.60 M
About Excellent Diagnostic And Research Agency
Excellent Diagnostic And Research Agency Private Limited (EDARAPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 July 2020 (Four years and seven months 1 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Energy And Power Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.60 M.
Upendra Trivedi and Mehulkumar Rajput serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2020PTC114623
-
Company No.
114623
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Jul 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Excellent Diagnostic And Research Agency?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Upendra Trivedi
|
Director | 15-Jul-2020 | Current |
|
Mehulkumar Rajput
|
Additional Director | 01-Apr-2021 | Current |
Financial Performance of Excellent Diagnostic And Research Agency.
Enhance accessibility to Excellent Diagnostic And Research Agency's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Excellent Diagnostic And Research Agency?
Unlock access to Excellent Diagnostic And Research Agency's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹4.60 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.46 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Dec 2024 | Others | ₹2.70 M | Open |
| 27 Jun 2022 | Others | ₹1.90 M | Open |
How Many Employees Work at Excellent Diagnostic And Research Agency?
Unlock and access historical data on people associated with Excellent Diagnostic And Research Agency, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Excellent Diagnostic And Research Agency, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excellent Diagnostic And Research Agency's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
